AU2516199A - Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors - Google Patents

Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors

Info

Publication number
AU2516199A
AU2516199A AU25161/99A AU2516199A AU2516199A AU 2516199 A AU2516199 A AU 2516199A AU 25161/99 A AU25161/99 A AU 25161/99A AU 2516199 A AU2516199 A AU 2516199A AU 2516199 A AU2516199 A AU 2516199A
Authority
AU
Australia
Prior art keywords
pyridinylpyrimidine
immunoglobuline
ige
amines
synthesis inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25161/99A
Inventor
Peter Ettmayer
Christoph Heusser
Max Woisetschlager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9800522.6A external-priority patent/GB9800522D0/en
Priority claimed from GBGB9800520.0A external-priority patent/GB9800520D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2516199A publication Critical patent/AU2516199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
AU25161/99A 1998-01-12 1999-01-08 Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors Abandoned AU2516199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9800520 1998-01-12
GBGB9800522.6A GB9800522D0 (en) 1998-01-12 1998-01-12 Organic compounds
GBGB9800520.0A GB9800520D0 (en) 1998-01-12 1998-01-12 Organic compounds
GB9800522 1998-01-12
PCT/EP1999/000060 WO1999035140A1 (en) 1998-01-12 1999-01-08 PYRIDINYLPYRIMIDINE AMINES AS IMMUNOGLOBULINE E (IgE) SYNTHESIS INHIBITORS

Publications (1)

Publication Number Publication Date
AU2516199A true AU2516199A (en) 1999-07-26

Family

ID=26312926

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25161/99A Abandoned AU2516199A (en) 1998-01-12 1999-01-08 Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors

Country Status (5)

Country Link
AR (1) AR014288A1 (en)
AU (1) AU2516199A (en)
CO (1) CO4940461A1 (en)
PE (1) PE20000174A1 (en)
WO (1) WO1999035140A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025820D0 (en) * 2000-10-20 2000-12-06 Novartis Ag Organic compounds
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
TW200302728A (en) * 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
EP2356102A1 (en) * 2008-11-14 2011-08-17 Bayer CropScience AG Substituted (pyridyl)-azinylamine derivatives as plant protection agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137979B1 (en) * 1983-09-01 1988-10-26 Boehringer Ingelheim Pharmaceuticals Inc. Diazine-ethenylphenyl oxamic acids and esters and salts thereof
AU691834B2 (en) * 1993-10-01 1998-05-28 Novartis Ag Pharmacologically active pyridine derivatives and processes for the preparation thereof
ES2262137T3 (en) * 1993-10-01 2006-11-16 Novartis Ag PHARMACOLOGICALLY ACTIVE PIRIMIDINAMINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.

Also Published As

Publication number Publication date
AR014288A1 (en) 2001-02-07
CO4940461A1 (en) 2000-07-24
WO1999035140A1 (en) 1999-07-15
PE20000174A1 (en) 2000-03-17

Similar Documents

Publication Publication Date Title
AU6477498A (en) Scale inhibitors
AU4429799A (en) Inhibitors of p38
AU3041199A (en) Device for peroperative exploration of cardiovascular system
AU2002315857A1 (en) Cell proliferation inhibitors containing anti-glypican 3 antibody
AUPQ679400A0 (en) Microgel synthesis
HUP0103366A3 (en) Amide derivatives which are useful as cytokine inhibitors
NO994201D0 (en) Frequency Synthesis Circuit
AU2002219555A1 (en) VLA-4 Inhibitors
HK1041407B (en) Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
AU5991699A (en) Quinolizinones as integrin inhibitors
EP1012139A4 (en) AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS
AU3868095A (en) Apolipoprotein-b synthesis inhibitors
AU2002357003A1 (en) Indoles as naaladase inhibitors
AU4723799A (en) Protease inhibitors
AU1530001A (en) Inhibitor compositions
AU1457299A (en) Novel signal transduction inhibitors, compositions containing them
AU9059798A (en) Urokinase inhibitors
AU5813299A (en) Apparatus for chip removal
AU4092799A (en) Protease inhibitors
AU2723099A (en) Tryptase inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU2516199A (en) Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors
AU2373600A (en) Novel spla2 inhibitors
AU1747501A (en) Novel ribose compounds
AU2713100A (en) Protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase